especially if there has been no prior discussion between the surrogates and patients and the needs of the patients are not known. Surrogates may also patients and what they think the patients themselves would want and may project their own needs on the patients 1 .
Previous work on surrogate decisions focused on patients suffering from chronic illnesses. This study aimed to compare the decisions on life-sustaining treatments between patients and their appointed surrogates in relatively healthy elective surgical patients.
METHODS
We obtained approval from the Institutional Review Board and written consent from all patients and their appointed surrogates for this study. We recruited patients who had general anaesthesia for elective surgery. These patients would have experienced a period of loss of control and unconsciousness similar to that in the intensive care unit. Both the surrogates and patients would also have experienced a period of uncertainty just prior to the interview.
The interviews were conducted at least 24 hours after surgery, to allow the patients to completely recover from general anaesthesia. We interviewed the patients and surrogates separately and advised them not to discuss their decisions with each other until both participants in every pair had been interviewed. We interviewed most patients and their designated surrogates sequentially on the same day. To avoid worsening any preoperative anxiety, we did not do preoperative interviews.
We standardised the interviews and obtained the patients' and surrogates' decisions on nine treatment options in each of three scenarios. The scenarios were: persistent vegetative state with no hope of waking up, coma with likely severe neurological damage and chronic disease complicated by dementia. The treatment options were: care in an intensive care unit, tracheal intubation and ventilation, cardiac support with inotropic drugs, cardiopulmonary resuscitation, enteral feeding, parenteral feeding, haemodialysis, surgery and transfusion of blood products. All the treatments were explained in detail with the aid of photographs. Their decisions were recorded as 'yes' or 'no' for all treatments.
In a subset of surrogates in the later stages of this study, we enquired about their decisions on the treatments for themselves if they were the patients in the imaginary scenarios. This was to evaluate the effect of projection of the surrogates' own preferences on what they thought the patients would want.
We also asked the participants if they knew of and understood advance directives or living wills and power of attorney, and whether the patients had previously discussed these instruments with their surrogates. We also obtained feedback on whether this study had caused the participants anxiety, whether they had found it useful in provoking thinking about critical illness scenarios and whether they thought there was a need for discussion about end-of-life medical decisions.
Statistics
We used SPSS version 13.0 for all analyses. We used the McNemar test for paired data to assess agreement between the patient and surrogate for each treatment option. We compiled a summary score for each patient and for each surrogate in each of the three scenarios. A score of one was given for each treatment that a participant decided 'yes' and zero when the participant decided 'no'. The minimum summary score for a scenario was 0 and the maximum summary score was 9. We compared the summary scores of the patients and surrogates for each scenario with the Wilcoxon signed rank test. In the subset of participants where the surrogates had also made decisions for themselves in the scenarios, we compared the summary scores using the Friedman two-way ANOVA tests for several related samples.
Our primary outcome measure was the summary score for the persistent vegetative state scenario. We estimated that the patients would have a median score of 3, regarded a difference of 2 as clinically important and estimated the standard deviation to be 2. Thirtyfour patients and 34 surrogates would be needed for 80% power with an alpha value of 0.05 in unpaired analysis. We estimated that 36 pairs would provide at least 80% power in paired analysis.
RESULTS
We interviewed a total of 36 pairs of patients and surrogates. The participants' characteristics and the relationship between the patients and surrogates are detailed in Table 1 .
The participants' decisions in the vegetative state scenario are presented in Table 2 . The patients and surrogates agreed in 176 of 324 (54.3%) decisions. The participants' decisions for the coma scenario are in Table 3 . The patients and surrogates agreed in 125 of 324 (38.5%) decisions. The participants' decisions for the chronic disease with dementia scenario are in Table 4 . The patients and surrogates agreed in 192 of 324 (59.2%) decisions.
The summary scores for each of the three scenarios higher for the surrogates' decisions in all three scenarios, indicating that the surrogates decided on far more treatment than the patients would have wanted. The summary scores for the 12 surrogates who were asked about treatment decisions for the surrogates themselves are in Table 6 . None of the not carry out post hoc tests. In the persistent vegetative state and chronic disease with dementia scenarios, the surrogates tended to decide on less treatment for themselves compared to what they decided for the patients.
Eighteen (50%) of the patients and 16 (44.4%) of the surrogates had some knowledge of advance discussed advance directives. Eighteen (50%) patients and 19 (52.8%) surrogates had some knowledge about power of attorney and only three pairs (8.3%) had previously discussed this instrument. Twelve (33%) of the patients and 10 (27.8%) of the surrogates felt some anxiety after the interviews. Twenty-seven (75%) of the patients and 28 (77.8%) of the surrogates felt that participating in this study had been useful in provoking thinking about their decisions in critical illness scenarios. Twenty-three (63.9%) of the patients and 27 (75%) of the surrogates thought that more discussion about end-of-life medical decisions was needed between individuals and their surrogate decision-makers. Only nine (25%) of the patients compared to 23 (63.9%) of the surrogates reported that knowing the costs of treatment would alter their decisions.
DISCUSSION
Our study showed poor agreement between patients and their surrogates in decision-making, with the proportion of agreement little better than that due to chance alone. The surrogates' decisions would have resulted in the patients having far more treatment than the patients would have wanted in all three scenarios. Second, in the subset of surrogates who were asked about treatment decisions for themselves, the surrogates wanted less treatment for themselves compared to what they chose for the patients. Third, our participants had a low level of knowledge of advance directives and power of attorney. Even if they were aware of these instruments, few had discussed these with their surrogates and family members.
One limitation of this study is that despite detailed explanations, the participants had variable understanding of the treatments and this may have the treatments discussed would require expedient decisions. Second, our study included only relatively healthy participants, none of whom had serious or terminal illnesses and who were relatively young compared to the general ICU population. This was because we felt that discussions of these treatments were best done when the subjects were healthy and there was no pressure to make decisions. Third, we had not assessed if patients and their surrogates had previously discussed life-sustaining treatments. This may be more likely if there had been ongoing serious illnesses or previous life-threatening illnesses. We are unable to evaluate if previous discussions surrogate decisions. Fourth, it is not realistic for the participants to make all the decisions at one interview as decisions on life-sustaining treatments occur over a period of time in clinical practice 2 .
populations that surrogates are unable to predict patients' treatment wishes 1, 3 . Such differences may be attributed to lack of previous discussion and knowledge of the patients' wishes 3, 4, 5 . A recent large meta-analysis found that not only was the accuracy of surrogate decisions poor, prior discussion did not improve accuracy 6 . The majority of studies in this meta-analysis found no trend in surrogates undertreating or over-treating the patients. In our study, to treat in the belief that the patients would have There did not appear to be projection of the surrogates' decisions for themselves on their decisions for the patients. The surrogates decided on less treatment for themselves if they were ill in similar scenarios compared to what they decided for the patients. Although surrogates were advised to make decisions based on what they thought the patients and of surrogates wanting to give the patients every possible chance of recovery. Even when patients have expressed their wishes in directives and discussions, some surrogates may still try to project their values when making decisions for the patients 7 . and caregivers may be as important as deciding on
In a multi-centre study, social workers actively their care 8 . They then tailored interventions such as family conferences, ethics consults, social service consults and pastoral care to reduce potential conthe already high satisfaction with ICU care, they did clarify patients' and surrogates' preferences. This increased the likelihood of patients and surrogates deciding to forgo resuscitation, choosing palliative care and also choosing aggressive care. Appointing surrogate decision-makers and delegating power of That surrogates decided on more treatment than the patients would have wanted may compound any breach of patient autonomy. Despite our efforts to clarify the questions, the surrogates may still have been unsure if they were making decisions according to what they thought the patients would want, rather than what the surrogates wanted for the patients.
practice and measures to reduce disagreements are needed.
Education of the public and facilitated discussions about advance directives may help to improve surrogates' decisions. In Singapore, the Ministry of Health has recently re-embarked on educating both the public and the medical community about advance medical directives. These advance medical directives are limited to situations where terminally ill patients are unconscious or incapable of expressing rational judgement and where death would be imminent regardless of the application of extraordinary lifesustaining treatments 9 . In situations similar to this study's imaginary scenarios, advance medical directives may not apply as death is not imminent and surrogates decisions will still be needed. Hence discussion between patients and their family members should be encouraged before the need for such care arises. Previous work showed that advance medical directives of decisions by surrogates 10, 11 . One study found that advanced directives could improve the accuracy of decisions by emergency and critical care doctors who were less familiar with the elderly patients, whereas there was no improvement in accuracy for family member surrogates and primary care doctors 12 .
In conclusion, there was poor agreement between surrogates' and patients' decisions in this study. While discussion of life-sustaining treatments can cause anxiety, most participants felt that there was a need for such discussion. We should explore if a combination of facilitated discussions and advance directives can improve the patient-surrogate relationship and understanding of the patients' wishes. Work is needed to improve the accuracy of surrogate decisions and better preserve and honour patients' autonomy.
